Maternal Mental Health: Postpartum Depression, Anxiety, and Getting Help

The Scope of Maternal Mental Health

The period surrounding pregnancy and childbirth—called the perinatal period—is a time of profound physical, hormonal, emotional, and social change. For many women, these changes bring joy and fulfillment. But for a significant portion, the perinatal period is also a time of vulnerability to mental health challenges that can range from mild and brief to severe and life-altering. Maternal mental health disorders are the most common complication of childbirth in the developed world; research estimates that between 15 and 20 percent of women experience a significant perinatal mood or anxiety disorder, yet the majority receive no treatment.

The term "postpartum depression" has entered the popular lexicon, but it is only one of several mental health conditions that can affect new mothers. The full spectrum of perinatal mood and anxiety disorders (PMADs) includes depression, anxiety, obsessive-compulsive disorder, post-traumatic stress disorder, and psychosis, all of which can occur during pregnancy or in the first year after birth. Each condition has distinct features, risk factors, and treatment approaches, though they often co-occur and the boundaries between them can blur in clinical practice. Understanding the full range of PMADs, rather than focusing narrowly on depression, helps women and their families recognize when something is wrong and seek appropriate help.

Postpartum mental health challenges do not affect only biological mothers. Adoptive parents, parents who used surrogates or donors, fathers and partners, and parents who have experienced pregnancy loss can all experience perinatal mood and anxiety disorders. Research consistently shows that partners of women with postpartum depression have elevated rates of depression themselves. Expanding our understanding of who is affected by maternal mental health challenges—and ensuring that care systems address all those affected—is an important goal for improving perinatal mental health outcomes.

The Baby Blues vs. Postpartum Depression: Understanding the Difference

One of the most important distinctions for new parents to understand is the difference between the "baby blues" and clinical postpartum depression. The baby blues is an extremely common experience—affecting up to 70 to 80 percent of new mothers—characterized by brief periods of mood swings, weepiness, anxiety, irritability, and emotional sensitivity that typically begin within the first few days after birth and resolve on their own within two weeks. The baby blues are thought to be largely driven by the dramatic hormonal changes that occur in the days after delivery, including sharp drops in estrogen and progesterone. They do not require treatment, though rest, support from family and friends, and compassionate understanding are helpful.

Postpartum depression (PPD) is distinguished from the baby blues by its greater severity, longer duration, and significant functional impairment. PPD affects approximately 10 to 15 percent of mothers—some estimates are higher—and it involves persistent sad or empty mood, loss of interest in activities, changes in sleep and appetite beyond what newborn care normally disrupts, difficulty concentrating, feelings of guilt or worthlessness, and sometimes intrusive thoughts about harm to self or baby. PPD can begin any time in the first year after birth, though it most commonly develops in the first few weeks to months. Unlike the baby blues, PPD does not resolve on its own without treatment and can persist for months or years if untreated.

A critical warning sign that distinguishes PPD from normal adjustment is the presence of intrusive thoughts—unwanted, distressing thoughts about harm coming to the baby. These thoughts, sometimes called "ego-dystonic" thoughts because they are experienced as foreign and horrifying rather than desired, are common in PPD and in postpartum OCD, and they reflect the new parent's intense anxiety about the baby's safety rather than any genuine intention to cause harm. Many mothers are terrified to disclose these thoughts to healthcare providers for fear of being judged as dangerous or having their baby removed. It is critically important for all new parents to know that intrusive thoughts are a symptom of a treatable illness, not evidence of bad parenting or dangerous intentions, and that disclosing them leads to help rather than punishment.

Postpartum Anxiety, OCD, and PTSD

Anxiety disorders are at least as common as depression in the postpartum period, and they are often under-recognized because the cultural narrative focuses primarily on sadness and depression. Postpartum anxiety affects approximately 15 percent of new mothers and is characterized by excessive worry, fear, and tension that interfere with functioning. Physical symptoms may include a racing heart, shortness of breath, muscle tension, and difficulty sleeping even when the baby is sleeping. Postpartum generalized anxiety disorder involves pervasive worry about many topics; postpartum panic disorder involves sudden episodes of intense fear with physical symptoms. Both require treatment and respond well to evidence-based therapies.

Postpartum OCD is a distinct condition that affects approximately 3 to 5 percent of new mothers and involves unwanted, intrusive, and repetitive thoughts (obsessions), often about harm coming to the baby, accompanied by compulsive behaviors aimed at reducing the anxiety triggered by those thoughts. A mother might constantly check that the baby is breathing, avoid certain activities out of fear of causing harm, or seek repeated reassurance from others that the baby is safe. The intrusive thoughts in postpartum OCD are ego-dystonic—the mother is horrified by them and desperately does not want to act on them—which distinguishes OCD from the rare and very different condition of postpartum psychosis, in which a mother may lose touch with reality.

Birth-related PTSD is also increasingly recognized as a significant postpartum mental health concern. Women who experience a traumatic birth—involving a sense of loss of control, fear for their own or the baby's life, emergency procedures, or being disrespected or mistreated during care—may develop PTSD characterized by flashbacks, nightmares, avoidance of reminders of the birth, hypervigilance, and emotional numbing. PTSD following childbirth is estimated to affect 3 to 4 percent of women, with higher rates among those who had objectively difficult or medically complicated births. Effective treatments for birth-related PTSD include trauma-focused cognitive behavioral therapy (TF-CBT) and eye movement desensitization and reprocessing (EMDR).

Postpartum Psychosis: A Psychiatric Emergency

Postpartum psychosis is a rare but extremely serious condition affecting approximately 1 to 2 per 1,000 births. It is a psychiatric emergency that requires immediate medical attention. Unlike postpartum depression and anxiety, which develop gradually, postpartum psychosis typically has a rapid onset—within the first two weeks after birth, often within the first few days. Symptoms include confusion and disorientation, hallucinations (seeing or hearing things that are not there), delusions (false beliefs that may involve the baby's identity or safety), extreme mood swings cycling between mania and depression, paranoia, and severely disorganized thinking and behavior.

Postpartum psychosis is distinct from the intrusive thoughts of PPD and OCD; a woman with postpartum psychosis may lose contact with reality in ways that can create genuine danger. Without prompt treatment, postpartum psychosis carries a small but real risk of infanticide and suicide, making it a true medical emergency. Women with a personal or family history of bipolar disorder are at particularly high risk; in women with bipolar disorder, the risk of postpartum psychosis may be as high as 25 to 50 percent. Treatment typically requires hospitalization in a psychiatric facility, preferably a mother-baby unit where the mother can maintain her relationship with her infant while receiving intensive care. Medications including mood stabilizers and antipsychotics are central to treatment. With appropriate treatment, most women recover fully, though they are at elevated risk for recurrence with subsequent pregnancies.

Because postpartum psychosis is rare and often misidentified as severe depression or simply attributed to exhaustion, it is important for family members and healthcare providers to be alert to its warning signs. If a new mother is experiencing confusion, losing touch with reality, hearing voices, or behaving in dangerous or bizarre ways, seeking emergency psychiatric evaluation immediately is essential. The American Academy of Pediatrics and other professional organizations include assessment for postpartum psychosis risk in their postpartum care guidelines, but widespread implementation of these guidelines remains a challenge.

Risk Factors and Prevention

Research has identified a number of risk factors that increase a woman's likelihood of developing a postpartum mood or anxiety disorder. The strongest risk factors include a personal history of depression, anxiety, or other mental health disorders; a previous perinatal mood disorder; a family history of perinatal mental health disorders; a history of trauma or adverse childhood experiences; and—for postpartum psychosis specifically—a personal or family history of bipolar disorder. Other significant risk factors include limited social support, relationship difficulties, financial stress, unplanned or unwanted pregnancy, pregnancy or birth complications, infant health problems, and having a premature or medically complex newborn.

While not all cases of postpartum mood disorders can be prevented, there are strategies that can reduce risk or facilitate early intervention. Women with known risk factors should discuss their mental health proactively with their OB/GYN, midwife, or primary care provider before or during pregnancy so that a mental health plan can be developed. Women with a history of depression may benefit from prophylactic treatment with antidepressants during pregnancy or immediately after delivery. All pregnant and postpartum women benefit from regular screening for symptoms of depression and anxiety, and many professional guidelines now recommend systematic screening at multiple points during pregnancy and in the postpartum period using validated tools such as the Edinburgh Postnatal Depression Scale.

Social and community supports play an important role in prevention and recovery. Strong social support—particularly a supportive partner, family, and friendship network—is one of the most powerful protective factors against postpartum mood disorders. New parent support groups, home visiting programs, and peer support programs staffed by women who have experienced and recovered from PMADs can reduce isolation, provide practical help, and connect new mothers with professional resources. Policies that support paid family leave, affordable childcare, and accessible maternal mental health care also contribute to prevention at a population level.

Treatment Options: What Works

Postpartum mood and anxiety disorders are highly treatable, and the large majority of affected women recover fully with appropriate care. Treatment options include psychotherapy, medication, and lifestyle interventions, and the best approach depends on the specific diagnosis, the severity of symptoms, and the patient's circumstances and preferences. Seeking help is a sign of strength, not weakness, and early treatment leads to better outcomes for both mother and baby.

Cognitive behavioral therapy (CBT) and interpersonal therapy (IPT) are evidence-based psychotherapies with the strongest evidence base for postpartum depression and anxiety. CBT helps patients identify and change unhelpful thought patterns and behaviors; IPT focuses on improving relationships and communication skills. Both approaches have been adapted specifically for the postpartum context. Therapy can be provided individually, in groups, or increasingly via telehealth, which has expanded access for women who cannot leave their homes or who live in areas without perinatal mental health specialists.

Antidepressant medications—primarily selective serotonin reuptake inhibitors (SSRIs) such as sertraline, fluoxetine, and paroxetine—are effective treatments for moderate to severe postpartum depression and anxiety. These medications are generally considered compatible with breastfeeding, as the amounts transferred in breast milk are typically low, and the benefits of treatment for both mother and baby generally outweigh the risks. In 2019, the FDA approved brexanolone (Zulresso), a synthetic analog of the neurosteroid allopregnanolone, as the first medication specifically developed and approved for postpartum depression. Given intravenously over 60 hours in a healthcare setting, brexanolone produces rapid relief in many patients and represents a significant advance in treatment. A related oral formulation, zuranolone (Zurzuvae), was approved in 2023 and is taken at home once daily for 14 days. Women with postpartum mood disorders should discuss all available treatment options with their healthcare provider, including the risks and benefits of medication during breastfeeding.